Sequence of CP3A4_HUMAN

1,8-cineole 2-exo-monooxygenase

P08684

503

57343

913373

Molowa D.T.,Schuetz E.G.,Wrighton S.A.,Watkins P.B.,Kremers P.,Mendez-Picon G.,Parker G.A.,Guzelian P.S.

Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver.

Proc. Natl. Acad. Sci. U.S.A.

83

5311-5315

1986

913374

Gonzalez F.J.,Schmid B.J.,Umeno M.,McBride O.W.,Hardwick J.P.,Meyer U.A.,Gelboin H.V.,Idle J.R.

Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase.

DNA

7

79-86

1988

913375

Beaune P.H.,Umbenhauer D.R.,Bork R.W.,Lloyd R.S.,Guengerich F.P.

Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase.

Proc. Natl. Acad. Sci. U.S.A.

83

8064-8068

1986

913376

Spurr N.K.,Gough A.C.,Stevenson K.,Wolf C.R.

The human cytochrome P450 CYP3 locus: assignment to chromosome 7q22-qter.

Hum. Genet.

81

171-174

1989

913377

Bork R.W.,Muto T.,Beaune P.H.,Srivastava P.K.,Lloyd R.S.,Guengerich F.P.

Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity.

J. Biol. Chem.

264

910-919

1989

913378

Chen Q.,Wu J.,Yu Y.

Establishment of transgenic cell line CHL-3A4 and its metabolic activation.

Zhonghua Yu Fang Yi Xue Za Zhi

32

281-284

1998

913379

Gellner K.,Eiselt R.,Hustert E.,Arnold H.,Koch I.,Haberl M.,Deglmann C.J.,Burk O.,Buntefuss D.,Escher S.,Bishop C.,Koebe H.-G.,Brinkmann U.,Klenk H.-P.,Kleine K.,Meyer U.A.,Wojnowski L.

Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene.

Pharmacogenetics

11

111-121

2001

913380

Hsieh K.-P.,Lin Y.-Y.,Cheng C.-L.,Lai M.-L.,Lin M.-S.,Siest J.-P.,Huang J.-D.

Novel mutations of CYP3A4 in Chinese.

Drug Metab. Dispos.

29

268-273

2001

913382

Komori M.,Hashizume T.,Ohi H.,Miura T.,Kitada M.,Nagashima K.,Kamataki T.

Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization.

J. Biochem.

104

912-916

1988

913383

Watkins P.B.,Wrighton S.A.,Maurel P.,Schuetz E.G.,Mendez-Picon G.,Parker G.A.,Guzelian P.S.

Identification of an inducible form of cytochrome P-450 in human liver.

Proc. Natl. Acad. Sci. U.S.A.

82

6310-6314

1985

913384

Aoyama T.,Yamano S.,Waxman D.J.,Lapenson D.P.,Meyer U.A.,Fischer V.,Tyndale R.,Inaba T.,Kalow W.,Gelboin H.V.,Gonzalez F.J.

Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.

J. Biol. Chem.

264

10388-10395

1989

913385

Shimada T.,Yamazaki H.,Mimura M.,Inui Y.,Guengerich F.P.

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

J. Pharmacol. Exp. Ther.

270

414-423

1994

913386

Kolars J.C.,Lown K.S.,Schmiedlin-Ren P.,Ghosh M.,Fang C.,Wrighton S.A.,Merion R.M.,Watkins P.B.

CYP3A gene expression in human gut epithelium.

Pharmacogenetics

4

247-259

1994

913387

Zhao X.J.,Yokoyama H.,Chiba K.,Wanwimolruk S.,Ishizaki T.

Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.

J. Pharmacol. Exp. Ther.

279

1327-1334

1996

913388

Bylund J.,Kunz T.,Valmsen K.,Oliw E.H.

Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes.

J. Pharmacol. Exp. Ther.

284

51-60

1998

913389

Rawden H.C.,Kokwaro G.O.,Ward S.A.,Edwards G.

Relative contribution of cytochromes P-450 and flavin-containing monooxygenases to the metabolism of albendazole by human liver microsomes.

Br. J. Clin. Pharmacol.

49

313-322

2000

913390

Chen H.,Howald W.N.,Juchau M.R.

Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes.

Drug Metab. Dispos.

28

315-322

2000

913391

Marill J.,Cresteil T.,Lanotte M.,Chabot G.G.

Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.

Mol. Pharmacol.

58

1341-1348

2000

913392

Miyazawa M.,Shindo M.,Shimada T.

Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.

Drug Metab. Dispos.

29

200-205

2001

913393

Badawi A.F.,Cavalieri E.L.,Rogan E.G.

Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.

Metabolism

50

1001-1003

2001

913394

Miyazawa M.,Shindo M.,Shimada T.

Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes.

Xenobiotica

31

713-723

2001

913395

Finta C.,Zaphiropoulos P.G.

Intergenic mRNA molecules resulting from trans-splicing.

J. Biol. Chem.

277

5882-5890

2002

913396

Lee A.J.,Conney A.H.,Zhu B.T.

Human cytochrome P450 3A7 has a distinct high catalytic activity for the 16alpha-hydroxylation of estrone but not 17beta-estradiol.

Cancer Res.

63

6532-6536

2003

913397

Lee A.J.,Cai M.X.,Thomas P.E.,Conney A.H.,Zhu B.T.

Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.

Endocrinology

144

3382-3398

2003

913398

Krauser J.A.,Voehler M.,Tseng L.H.,Schefer A.B.,Godejohann M.,Guengerich F.P.

Testosterone 1 beta-hydroxylation by human cytochrome P450 3A4.

Eur. J. Biochem.

271

3962-3969

2004

913399

Choi M.H.,Skipper P.L.,Wishnok J.S.,Tannenbaum S.R.

Characterization of testosterone 11 beta-hydroxylation catalyzed by human liver microsomal cytochromes P450.

Drug Metab. Dispos.

33

714-718

2005

913400

Dauchy S.,Dutheil F.,Weaver R.J.,Chassoux F.,Daumas-Duport C.,Couraud P.O.,Scherrmann J.M.,De Waziers I.,Decleves X.

ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier.

J. Neurochem.

107

1518-1528

2008

913401

Agarwal V.,Kommaddi R.P.,Valli K.,Ryder D.,Hyde T.M.,Kleinman J.E.,Strobel H.W.,Ravindranath V.

Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite.

PLoS ONE

3

0-0

2008

913402

Pabarcus M.K.,Hoe N.,Sadeghi S.,Patterson C.,Wiertz E.,Correia M.A.

CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases.

Arch. Biochem. Biophys.

483

66-74

2009

913403

Dutheil F.,Dauchy S.,Diry M.,Sazdovitch V.,Cloarec O.,Mellottee L.,Bieche I.,Ingelman-Sundberg M.,Flinois J.P.,de Waziers I.,Beaune P.,Decleves X.,Duyckaerts C.,Loriot M.A.

Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function.

Drug Metab. Dispos.

37

1528-1538

2009

913404

Pratt-Hyatt M.,Zhang H.,Snider N.T.,Hollenberg P.F.

Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide.

Drug Metab. Dispos.

38

2075-2082

2010

913405

Lucas D.,Goulitquer S.,Marienhagen J.,Fer M.,Dreano Y.,Schwaneberg U.,Amet Y.,Corcos L.

Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450.

J. Lipid Res.

51

1125-1133

2010

913406

Peng C.C.,Templeton I.,Thummel K.E.,Davis C.,Kunze K.L.,Isoherranen N.

Evaluation of 6beta-hydroxycortisol, 6beta-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo.

Clin. Pharmacol. Ther.

89

888-895

2011

913407

Honda A.,Miyazaki T.,Ikegami T.,Iwamoto J.,Maeda T.,Hirayama T.,Saito Y.,Teramoto T.,Matsuzaki Y.

Cholesterol 25-hydroxylation activity of CYP3A.

J. Lipid Res.

52

1509-1516

2011

913408

Cheng Q.,Sohl C.D.,Yoshimoto F.K.,Guengerich F.P.

Oxidation of dihydrotestosterone by human cytochromes P450 19A1 and 3A4.

J. Biol. Chem.

287

29554-29567

2012

913409

Bian Y.,Song C.,Cheng K.,Dong M.,Wang F.,Huang J.,Sun D.,Wang L.,Ye M.,Zou H.

An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

J. Proteomics

96

253-262

2014

913410

Kabe Y.,Nakane T.,Koike I.,Yamamoto T.,Sugiura Y.,Harada E.,Sugase K.,Shimamura T.,Ohmura M.,Muraoka K.,Yamamoto A.,Uchida T.,Iwata S.,Yamaguchi Y.,Krayukhina E.,Noda M.,Handa H.,Ishimori K.,Uchiyama S.,Kobayashi T.,Suematsu M.

Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance.

Nat. Commun.

7

11030-11030

2016

913411

Yano J.K.,Wester M.R.,Schoch G.A.,Griffin K.J.,Stout C.D.,Johnson E.F.

The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution.

J. Biol. Chem.

279

38091-38094

2004

913412

Williams P.A.,Cosme J.,Vinkovic D.M.,Ward A.,Angove H.C.,Day P.J.,Vonrhein C.,Tickle I.J.,Jhoti H.

Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.

Science

305

683-686

2004

913413

Sata F.,Sapone A.,Elizondo G.,Stocker P.,Miller V.P.,Zheng W.,Raunio H.,Crespi C.L.,Gonzalez F.J.

CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity.

Clin. Pharmacol. Ther.

67

48-56

2000

913414

Dai D.,Tang J.,Rose R.,Hodgson E.,Bienstock R.J.,Mohrenweiser H.W.,Goldstein J.A.

Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos.

J. Pharmacol. Exp. Ther.

299

825-831

2001

913415

Eiselt R.,Domanski T.L.,Zibat A.,Mueller R.,Presecan-Siedel E.,Hustert E.,Zanger U.M.,Brockmoller J.,Klenk H.-P.,Meyer U.A.,Khan K.K.,He Y.-A.,Halpert J.R.,Wojnowski L.

Identification and functional characterization of eight CYP3A4 protein variants.

Pharmacogenetics

11

447-458

2001

913416

Lamba J.K.,Lin Y.S.,Thummel K.,Daly A.,Watkins P.B.,Strom S.,Zhang J.,Schuetz E.G.

Common allelic variants of cytochrome P4503A4 and their prevalence in different populations.

Pharmacogenetics

12

121-132

2002

913417

Solus J.F.,Arietta B.J.,Harris J.R.,Sexton D.P.,Steward J.Q.,McMunn C.,Ihrie P.,Mehall J.M.,Edwards T.L.,Dawson E.P.

Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.

Pharmacogenomics

5

895-931

2004

913418

Roizen J.D.,Li D.,O'Lear L.,Javaid M.K.,Shaw N.J.,Ebeling P.R.,Nguyen H.H.,Rodda C.P.,Thummel K.E.,Thacher T.D.,Hakonarson H.,Levine M.A.

CYP3A4 mutation causes vitamin D-dependent rickets type 3.

J. Clin. Invest.

128

1913-1918

2018